Skip to main content

Advertisement

Log in

Optimization of valencene containing lipid vesicles for boosting the transungual delivery of itraconazole

  • Original Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

The objective of the present study was to prepare valencene (sesquiterpene) containing invasomes for itraconazole (ITZ) transungual delivery using central composite design. The phospholipid (X1) and valencene (X2) were selected as an independent variables, while vesicles size (Y1), entrapment efficiency (Y2) and in vitro drug release (Y3) were chosen as dependent variables. The antifungal activity of optimized formulation was screened against Trichophyton rubrum, a common causative onychomycosis pathogen, by cup plate method. The optimized ITZ-loaded invasomes formulation presented vesicles size of 176.8 ± 6.03 nm, entrapment efficiency of 83.21 ± 4.11% and in vitro drug release of 75.22 ± 5.03%. The ITZ-loaded invasomes gel formulation showed good homogeneity, pH 6.5 ± 0.23, viscosity 7.33 ± 0.67 Pa s and drug content 94.13 ± 1.13%. The spreadability and extrudability of developed ITZ-loaded invasomes gel were found to be 7.85 ± 0.24 gcm/s and 162 ± 2.74 g, respectively. The ITZ-loaded invasomes gel presented 71.11 ± 3.65% cumulative permeation of drug via goat hooves. The in vitro antifungal activity depicted that the ITZ-loaded invasomes gel and marketed preparation were presented zone of inhibition of 21.42 mm and 10.64 mm against T. rubrum respectively. Hence the prepared ITZ-loaded invasomes formulation could therefore be a promising topical dosage to mitigate the indications and hasten the cure for onychomycosis than conventional available therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  • Abdellatif AA, Tawfeek HM (2016) Transfersomal Nanoparticles for Enhanced Transdermal Delivery of Clindamycin. AAPS PharmSciTech 17:1067–1074

    Article  CAS  Google Scholar 

  • Abdollahi D, Jafariazar Z, Afshar M (2020) Effect of monoterpenes on ex vivo transungual delivery of itraconazole for the management of onychomycosis. J Cosmet Dermatol 19:2745–2751

    Article  Google Scholar 

  • Ahad A, Aqil M, Kohli K, Chaudhary H, Sultana Y, Mujeeb M, Talegaonkar S (2009) Chemical penetration enhancers: a patent review. Expert Opin Ther Pat 19:969–988

    Article  CAS  Google Scholar 

  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A (2011a) Role of novel terpenes in transcutaneous permeation of valsartan: effectiveness and mechanism of action. Drug Dev Ind Pharm 37:583–596

    Article  CAS  Google Scholar 

  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M, Ali A (2011b) Interactions between novel terpenes and main components of rat and human skin: mechanistic view for transdermal delivery of propranolol hydrochloride. Curr Drug Deliv 8:213–224

    Article  CAS  Google Scholar 

  • Ahad A, Aqil M, Kohli K, Sultana Y, Mujeeb M (2014) Design, formulation and optimization of valsartan transdermal gel containing iso-eucalyptol as novel permeation enhancer: preclinical assessment of pharmacokinetics in Wistar albino rats. Expert Opin Drug Deliv 11:1149–1162

    Article  CAS  Google Scholar 

  • Ahad A, Aqil M, Ali A (2016) The application of anethole, menthone, and eugenol in transdermal penetration of valsartan: enhancement and mechanistic investigation. Pharm Biol 54:1042–1051

    Article  CAS  Google Scholar 

  • Ahad A, Raish M, Ahmad A, Al-Jenoobi FI, Al-Mohizea AM (2018a) Development and biological evaluation of vesicles containing bile salt of telmisartan for the treatment of diabetic nephropathy. Artif Cells Nanomed Biotechnol 46:532–539

    Article  CAS  Google Scholar 

  • Ahad A, Raish M, Ahmad A, Al-Jenoobi FI, Al-Mohizea AM (2018b) Eprosartan mesylate loaded bilosomes as potential nano-carriers against diabetic nephropathy in streptozotocin-induced diabetic rats. Eur J Pharm Sci 111:409–417

    Article  CAS  Google Scholar 

  • Ammar HO, Mohamed MI, Tadros MI, Fouly AA (2018) Transdermal delivery of ondansetron hydrochloride via bilosomal systems. In vitro, ex vivo, and in vivo characterization studies. AAPS PharmSciTech 19:2276–2287

    Article  CAS  Google Scholar 

  • Aqil M, Ahad A, Sultana Y, Ali A (2007) Status of terpenes as skin penetration enhancers. Drug Discov Today 12:1061–1067

    Article  CAS  Google Scholar 

  • Babaie S, Bakhshayesh ARD, Ha JW, Hamishehkar H, Kim KH (2020) Invasome: a novel nanocarrier for transdermal drug delivery. Nanomaterials (Basel) 10:341

    Article  CAS  Google Scholar 

  • Bachhav YG, Patravale VB (2009) Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation. Int J Pharm 365:175–179

    Article  CAS  Google Scholar 

  • Barot BS, Parejiya PB, Patel HK, Mehta DM, Shelat PK (2012) Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies. Drug Deliv Transl Res 2:463–476

    Article  CAS  Google Scholar 

  • Bommannan D, Potts RO, Guy RH (1991) Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. J Control Release 16:299–304

    Article  CAS  Google Scholar 

  • Chaudhary H, Kohli K, Amin S, Rathee P, Kumar V (2011) Optimization and formulation design of gels of Diclofenac and Curcumin for transdermal drug delivery by Box–Behnken statistical design. J Pharm Sci 100:580–593

    Article  CAS  Google Scholar 

  • Dragicevic-Curic N, Grafe S, Albrecht V, Fahr A (2008) Topical application of temoporfin-loaded invasomes for photodynamic therapy of subcutaneously implanted tumours in mice: a pilot study. J Photochem Photobiol B 91:41–50

    Article  CAS  Google Scholar 

  • Dragicevic-Curic N, Scheglmann D, Albrecht V, Fahr A (2009) Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies. Colloids Surf B Biointerfaces 70:198–206

    Article  CAS  Google Scholar 

  • Dragicevic-Curic N, Friedrich M, Petersen S, Scheglmann D, Douroumis D, Plass W, Fahr A (2011) Assessment of fluidity of different invasomes by electron spin resonance and differential scanning calorimetry. Int J Pharm 412:85–94

    Article  CAS  Google Scholar 

  • El-Nabarawi MA, Shamma RN, Farouk F, Nasralla SM (2018) Dapsone-loaded invasomes as a potential treatment of acne: preparation, characterization, and in vivo skin deposition assay. AAPS PharmSciTech 19:2174–2184

    Article  CAS  Google Scholar 

  • Gupta AK, Stec N (2019) Emerging drugs for the treatment of onychomycosis. Expert Opin Emerg Drugs 24:213–220

    Article  CAS  Google Scholar 

  • Gupta AK, De Doncker P, Scher RK, Haneke E, Daniel CR 3rd, Andre J, Baran R (1998) Itraconazole for the treatment of onychomycosis. Int J Dermatol 37:303–308

    Article  CAS  Google Scholar 

  • Gupta AK, Albreski D, Del Rosso JQ, Konnicov N (2001) The use of the new oral antifungal agents, itraconazole, terbinafine, and fluconazole, to treat onychomycosis and other dermatomycoses. Curr Probl Dermatol 13:220–246

    Article  Google Scholar 

  • Hamed Khater M, Khattab FM (2020) Combined long-pulsed Nd-Yag laser and itraconazole versus itraconazole alone in the treatment of onychomycosis nails. J Dermatol Treat 31:406–409

    Article  CAS  Google Scholar 

  • Jain S, Sehgal VN (2003) Itraconazole versus terbinafine in the management of onychomycosis: an overview. J Dermatol Treat 14:30–42

    Article  CAS  Google Scholar 

  • Kamran M, Ahad A, Aqil M, Imam SS, Sultana Y, Ali A (2016) Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: in vitro characterization and in vivo pharmacokinetic assessment. Int J Pharm 505:147–158

    Article  CAS  Google Scholar 

  • Kushwaha A, Jacob M, Shiva Kumar HN, Hiremath S, Aradhya S, Repka MA, Murthy SN (2015) Trans-ungual delivery of itraconazole hydrochloride by iontophoresis. Drug Dev Ind Pharm 41:1089–1094

    Article  CAS  Google Scholar 

  • Mahtab A, Anwar M, Mallick N, Naz Z, Jain GK, Ahmad FJ (2016) Transungual delivery of ketoconazole nanoemulgel for the effective management of onychomycosis. AAPS PharmSciTech 17:1477–1490

    Article  CAS  Google Scholar 

  • Pal P, Thakur RS, Ray S, Mazumder B (2015) Design and development of a safer non-invasive transungual drug delivery system for topical treatment of onychomycosis. Drug Dev Ind Pharm 41:1095–1099

    Article  CAS  Google Scholar 

  • Parikh SK, Patel AD, Dave JB, Patel CN, Sen DJ (2011) Development and validation of UV spectrophotometric method for estimation of itraconazole bulk drug and pharmaceutical formulation. Int J Drug Dev Res 3:324–328

    CAS  Google Scholar 

  • Qadri GR, Ahad A, Aqil M, Imam SS, Ali A (2017) Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study. Artif Cells Nanomed Biotechnol 45:139–145

    Article  CAS  Google Scholar 

  • Shah SM, Ashtikar M, Jain AS, Makhija DT, Nikam Y, Gude RP, Steiniger F, Jagtap AA, Nagarsenker MS, Fahr A (2015) LeciPlex, invasomes, and liposomes: a skin penetration study. Int J Pharm 490:391–403

    Article  CAS  Google Scholar 

  • Thapa C, Ahad A, Aqil M, Imam SS, Sultana Y (2018) Formulation and optimization of nanostructured lipid carriers to enhance oral bioavailability of telmisartan using Box–Behnken design. J Drug Deliv Sci Technol 44:431–439

    Article  CAS  Google Scholar 

  • Thatai P, Sapra B (2014) Transungual delivery: deliberations and creeds. Int J Cosmet Sci 36:398–411

    Article  CAS  Google Scholar 

  • Thatai P, Sapra B (2017) Transungual gel of terbinafine hydrochloride for the management of onychomycosis: formulation, optimization, and evaluation. AAPS PharmSciTech 18:2316–2328

    Article  CAS  Google Scholar 

  • Zhang L, Xu H, Shi Y, Yu J, Tao Y, Li X (2018) An exploration of the optimum dosage and number of cycles of itraconazole pulse therapy for severe onychomycosis. Mycoses 61:736–742

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

QH: Investigation, formulation, methodology. MA: Ideas, supervision, conceptualization. AA: Software, writing-original draft preparation. SSI: Software, interpreting the data. AP: Data collection. AQ: Review and editing. ZI: Ideas, design of methodology

Corresponding authors

Correspondence to Mohd. Aqil or Abdul Ahad.

Ethics declarations

Conflict of interest

The authors report no declarations of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hoda, Q., Aqil, M., Ahad, A. et al. Optimization of valencene containing lipid vesicles for boosting the transungual delivery of itraconazole. 3 Biotech 11, 137 (2021). https://doi.org/10.1007/s13205-020-02497-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-020-02497-7

Keywords

Navigation